We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.11B
AUM Growth
-$20.5M
Cap. Flow
-$108M
Cap. Flow %
-9.76%
Top 10 Hldgs %
45.22%
Holding
2,962
New
135
Increased
1,005
Reduced
918
Closed
188

Top Sells

Rank Stock Value
1
WDAY icon
Workday
WDAY
+$72.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$13.2M
3
GBDC icon
Golub Capital BDC
GBDC
+$6.44M
4
AAPL icon
Apple
AAPL
+$3.78M
5
NMFC icon
New Mountain Finance
NMFC
+$3.74M

Sector Composition

Rank Sector Weight
1 Technology 17.89%
2 Financials 11.68%
3 Healthcare 4.7%
4 Communication Services 4.55%
5 Consumer Discretionary 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFBS
2151
ServisFirst Bancshares
SFBS
$4.86B
$3.22K ﹤0.01%
38
MCB icon
2152
Metropolitan Bank Holding Corp
MCB
$1.15B
$3.21K ﹤0.01%
55
MRUS
2153
DELISTED
Merus
MRUS
$3.2K ﹤0.01%
76
FSLY icon
2154
Fastly Inc
FSLY
$3.66B
$3.19K ﹤0.01%
338
+47
+16% +$390
GRC icon
2155
Gorman-Rupp
GRC
$2.21B
$3.19K ﹤0.01%
84
HL icon
2156
Hecla Mining
HL
$11.3B
$3.18K ﹤0.01%
647
-1,085
-63% -$6.48K
SIL icon
2157
Global X Silver Miners ETF NEW
SIL
$4.74B
$3.18K ﹤0.01%
100
STRA icon
2158
Strategic Education
STRA
$1.92B
$3.18K ﹤0.01%
34
GBCI icon
2159
Glacier Bancorp
GBCI
$6.35B
$3.16K ﹤0.01%
63
BWIN
2160
Baldwin Insurance Group
BWIN
$2.86B
$3.14K ﹤0.01%
81
RVNC
2161
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.14K ﹤0.01%
1,032
+398
+63% +$1.73K
DY icon
2162
Dycom Industries
DY
$12.3B
$3.13K ﹤0.01%
18
-13
-42% -$2.4K
PLAB icon
2163
Photronics
PLAB
$1.93B
$3.13K ﹤0.01%
133
+4
+3% +$98
SBGI icon
2164
Sinclair Inc
SBGI
$1.03B
$3.13K ﹤0.01%
194
BRSP
2165
BrightSpire Capital
BRSP
$648M
$3.11K ﹤0.01%
552
-220
-28% -$1.3K
KAI icon
2166
Kadant
KAI
$3.99B
$3.1K ﹤0.01%
9
ACA icon
2167
Arcosa
ACA
$7.11B
$3.1K ﹤0.01%
32
UAA icon
2168
Under Armour
UAA
$2.6B
$3.09K ﹤0.01%
373
-207
-36% -$1.89K
CALX icon
2169
Calix
CALX
$2.39B
$3.07K ﹤0.01%
88
-336
-79% -$11.8K
DHT icon
2170
DHT Holdings
DHT
$3.02B
$3.05K ﹤0.01%
328
+109
+50% +$1.12K
HAE icon
2171
Haemonetics
HAE
$4B
$3.04K ﹤0.01%
39
LESL icon
2172
Leslie's
LESL
$11M
$3.04K ﹤0.01%
68
+17
+33% +$903
NX icon
2173
Quanex
NX
$1.01B
$3.03K ﹤0.01%
125
ASTH icon
2174
Astrana Health
ASTH
$1.77B
$3.03K ﹤0.01%
96
-12
-11% -$570
ACAD icon
2175
Acadia Pharmaceuticals
ACAD
$5.03B
$3.01K ﹤0.01%
164
+38
+30% +$613

Similar funds

Lindbrook Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Lindbrook Capital held 2,962 positions worth $1.11B, down 1.8% from $1.13B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Lindbrook Capital withdrew a net $108M in Q4 2024, closing 188 positions and reducing 918 holdings. Its most notable exit was Marathon Oil Corporation, an estimated $215K position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lindbrook Capital opened a new position in Septerna Inc worth $481K.

  • Lindbrook Capital's largest Q4 2024 buy was Septerna Inc: 21,000 shares worth $481K.
  • Lindbrook Capital added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $2.05M increase.
  • Lindbrook Capital's biggest Q4 2024 reduction was Workday, cutting an estimated $72.9M.
  • Lindbrook Capital fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $215K.
  • Lindbrook Capital's ten largest holdings make up 45% of its $1.11B portfolio in Q4 2024.
  • Lindbrook Capital opened 135 new positions and closed 188 in Q4 2024.
  • Lindbrook Capital's portfolio value fell 1.8% quarter-over-quarter to $1.11B.

Based on Lindbrook Capital's 13F filing for Q4 2024, filed 6 Feb 2025.